{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:13:10Z","timestamp":1774534390081,"version":"3.50.1"},"reference-count":53,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Discoid Lupus Erythematosus (DLE) is a chronic cutaneous disease of unknown etiology and of immunoinflammatory origin that is characterized by inflammatory plaques and may lead to disfiguring scarring and skin atrophy. Current treatments are limited, with a large proportion of patients either poorly or not responsive, which makes DLE an unmet medical need. Macrophage migration inhibitory factor (MIF) is the prototype of a pleiotropic family of cytokine that also includes the recently discovered homologue D-dopachrome tautomerase (DDT) or MIF2. MIF and DDT\/MIF-2 exert several biological properties, primarily, but not exclusively of a proinflammatory nature. MIF and DDT have been suggested to play a key role in the pathogenesis of several autoimmune diseases, such as multiple sclerosis and type 1 diabetes, as well as in the development and progression of certain forms of cancers. In the present study, we have performed an immunohistochemistry analysis for the evaluation of MIF in DLE lesions and normal skin. We found high levels of MIF in the basal layer of the epidermis as well as in the cutaneous appendage (eccrine glands and sebocytes) of normal skin. In DLE lesions, we observed a significant negative correlation between the expression of MIF and the severity of inflammation. In addition, we performed an analysis of MIF and DDT expression levels in the skin of DLE patients in a publicly available microarray dataset. Interestingly, while these in silico data only evidenced a trend toward reduced levels of MIF, they demonstrated a significant pattern of expression and correlation of DDT with inflammatory infiltrates in DLE skins. Overall, our data support a protective role for endogenous MIF and possibly DDT in the regulation of homeostasis and inflammation in the skin and open up novel avenues for the treatment of DLE.<\/jats:p>","DOI":"10.3390\/molecules26010184","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T22:35:48Z","timestamp":1609540548000},"page":"184","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Macrophage Migration Inhibitory Factor (MIF) and Its Homologue D-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-8010","authenticated-orcid":false,"given":"Rosario","family":"Caltabiano","sequence":"first","affiliation":[{"name":"Department of Medical, Surgical and Advanced Technologies \u201cG.F. Ingrassia\u201d, University of Catania, Via Santa Sofia, 87, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"De Pasquale","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Piombino","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Advanced Technologies \u201cG.F. Ingrassia\u201d, University of Catania, Via Santa Sofia, 87, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Campo","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-8462","authenticated-orcid":false,"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Cavalli","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5920-4620","authenticated-orcid":false,"given":"Katia","family":"Mangano","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-1992","authenticated-orcid":false,"given":"Paolo","family":"Fagone","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11926-020-00946-z","article-title":"An update on the pathogenesis of cutaneous lupus erythematosus and its role in clinical practice","volume":"22","author":"Patel","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/sder.2001.23091","article-title":"Cutaneous lupus erythematosus","volume":"20","author":"McCauliffe","year":"2001","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_3","first-page":"CD002954","article-title":"Drugs for discoid lupus erythematosus","volume":"2017","author":"Jessop","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2019.07.010","article-title":"Management of cutaneous manifestations of lupus erythematosus: A systematic review","volume":"50","author":"Fairley","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2008.07.037","article-title":"MIF in autoimmunity and novel therapeutic approaches","volume":"8","author":"Stojanovic","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E8421","DOI":"10.1073\/pnas.1712288114","article-title":"MIF and D-DT are potential disease severity modifiers in male MS subjects","volume":"114","author":"Benedek","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2018.06.009","article-title":"Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences","volume":"322","author":"Fagone","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.drudis.2018.11.003","article-title":"Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: From pathogenic factors to therapeutic targets","volume":"24","author":"Fagone","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"17951","DOI":"10.18632\/oncotarget.24885","article-title":"Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach","volume":"9","author":"Mangano","year":"2018","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.it.2019.03.002","article-title":"Rediscovering MIF: New tricks for an old cytokine","volume":"40","author":"Harris","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: Function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","article-title":"Evolving complexity of MIF signaling","volume":"57","author":"Jankauskas","year":"2019","journal-title":"Cell. Signal."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41467-018-04581-2","article-title":"Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation","volume":"9","author":"Lang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40672","article-title":"Macrophage migration inhibitory factor regulates U1 small nuclear RNP immune complex-mediated activation of the NLRP3 inflammasome","volume":"71","author":"Shin","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cavalli, E., Mazzon, E., Basile, M.S., Mangano, K., Di Marco, R., Bramanti, P., Nicoletti, F., Fagone, P., and Petralia, M.C. (2019). Upregulated expression of macrophage migration inhibitory factor, its analogue D-dopachrome tautomerase, and the CD44 receptor in peripheral CD4 t cells from clinically isolated syndrome patients with rapid conversion to clinical defined multiple sclerosis. Medicina (B Aires), 55.","DOI":"10.3390\/medicina55100667"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2005.07.019","article-title":"Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barr\u00e9 syndrome and experimental allergic neuritis","volume":"168","author":"Nicoletti","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2019.11.127","article-title":"Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches","volume":"263","author":"Petralia","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fimmu.2015.00577","article-title":"MIF: Implications in the pathoetiology of systemic lupus erythematosus","volume":"6","author":"Lang","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cellimm.2017.12.010","article-title":"MIF promotes a differential Th1\/Th2\/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-\u03b1 in PBMC from active SLE patients","volume":"324","author":"Bucala","year":"2018","journal-title":"Cell. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3389\/fonc.2019.01145","article-title":"Immunobiology of uveal melanoma: State of the art and therapeutic targets","volume":"9","author":"Basile","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3389\/fimmu.2018.01132","article-title":"Blockade of MIF-CD74 signalling on macrophages and dendritic cells restores the antitumour immune response against metastatic melanoma","volume":"9","author":"Figueiredo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Soumoy, L., Kindt, N., Ghanem, G., Saussez, S., and Journe, F. (2019). Role of macrophage migration inhibitory factor (MIF) in melanoma. Cancers (Basel), 11.","DOI":"10.3390\/cancers11040529"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cavalli, E., Ciurleo, R., Petralia, M.C., Fagone, P., Bella, R., Mangano, K., Nicoletti, F., Bramanti, P., and Basile, M.S. (2020). Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets?. Molecules, 25.","DOI":"10.3390\/molecules25051194"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/hed.24939","article-title":"Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review","volume":"39","author":"Lechien","year":"2017","journal-title":"Head Neck"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Cavalli, E., Mazzon, E., Mammana, S., Basile, M.S., Lombardo, S.D., Mangano, K., Bramanti, P., Nicoletti, F., Fagone, P., and Petralia, M.C. (2019). Overexpression of macrophage migration inhibitory factor and its homologue D-dopachrome tautomerase as negative prognostic factor in neuroblastoma. Brain Sci., 9.","DOI":"10.3390\/brainsci9100284"},{"key":"ref_26","first-page":"2881","article-title":"Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma","volume":"16","author":"Presti","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.18632\/oncotarget.23862","article-title":"Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis","volume":"9","author":"Mammana","year":"2018","journal-title":"Oncotarget"},{"key":"ref_28","first-page":"2055","article-title":"Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression","volume":"18","author":"Petralia","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Petralia, M.C., Mazzon, E., Fagone, P., Russo, A., Longo, A., Avitabile, T., Nicoletti, F., Reibaldi, M., and Basile, M.S. (2019). Characterization of the pathophysiological role of CD47 in uveal melanoma. Molecules, 24.","DOI":"10.3390\/molecules24132450"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Basile, M.S., Mazzon, E., Russo, A., Mammana, S., Longo, A., Bonfiglio, V., Fallico, M., Caltabiano, R., Fagone, P., and Nicoletti, F. (2019). Differential modulation and prognostic values of immune-escape genes in uveal melanoma. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210276"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2133.1999.03206.x","article-title":"Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease","volume":"141","author":"Steinhoff","year":"1999","journal-title":"Br. J. Derm."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yamamoto, T. (2020). Psoriasis and connective tissue diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165803"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/jid.2013.269","article-title":"Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis","volume":"134","author":"Jabbari","year":"2014","journal-title":"J. Investig. Derm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0625.2010.01194.x","article-title":"MIF: A key player in cutaneous biology and wound healing","volume":"20","author":"Gilliver","year":"2011","journal-title":"Exp. Derm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF03401765","article-title":"Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth","volume":"4","author":"Takahashi","year":"1998","journal-title":"Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.190.10.1375","article-title":"A proinflammatory cytokine inhibits p53 tumor suppressor activity","volume":"190","author":"Hudson","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fimmu.2020.01273","article-title":"Role of MIF Cytokine\/CD74 receptor pathway in protecting against injury and promoting repair","volume":"11","author":"Farr","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","article-title":"An essential regulatory role for macrophage migration inhibitory factor in T-cell activation","volume":"93","author":"Bacher","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nature06504","article-title":"Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart","volume":"451","author":"Miller","year":"2008","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e2008","DOI":"10.1038\/cddis.2015.349","article-title":"Macrophage migration inhibitory factor has a permissive role in concanavalin A-induced cell death of human hepatoma cells through autophagy","volume":"6","author":"Lai","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2015.02.034","article-title":"Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1","volume":"86","author":"Israelson","year":"2015","journal-title":"Neuron"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41419-017-0130-4","article-title":"MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: Implications for familial ALS","volume":"9","author":"Shvil","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"14755","DOI":"10.1073\/pnas.1904665116","article-title":"AAV2\/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS","volume":"116","author":"Kahn","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/CS20181013","article-title":"Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection","volume":"133","author":"Ruze","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"eaan4886","DOI":"10.1126\/scitranslmed.aan4886","article-title":"The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery","volume":"10","author":"Stoppe","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Basile, M.S., Battaglia, G., Bruno, V., Mangano, K., Fagone, P., Petralia, M.C., Nicoletti, F., and Cavalli, E. (2020). The dichotomic role of macrophage migration inhibitory factor in neurodegeneration. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21083023"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Petralia, M.C., Battaglia, G., Bruno, V., Pennisi, M., Mangano, K., Lombardo, S.D., Fagone, P., Cavalli, E., Saraceno, A., and Nicoletti, F. (2020). The role of macrophage migration inhibitory factor in Alzheimer\u2019s disease: Conventionally pathogenetic or unconventionally protective?. Molecules, 25.","DOI":"10.3390\/molecules25020291"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1803583","article-title":"Phase 2 trial of ibudilast in progressive multiple sclerosis","volume":"379","author":"Fox","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/imt-2017-0136","article-title":"Emerging immune targets for the treatment of multiple myeloma","volume":"10","author":"Sohail","year":"2018","journal-title":"Immunotherapy"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1158\/1055-9965.EPI-11-0279","article-title":"Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: A potential biomarker for anti-inflammatory intervention","volume":"20","author":"Healy","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_51","unstructured":"Calonje, E. (2012). McKee\u2019s Pathology of the Skin: With Clinical Correlations, Elsevier\/Saunders."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Broggi, G., Musumeci, G., Puzzo, L., Russo, A., Reibaldi, M., Ragusa, M., Longo, A., and Caltabiano, R. (2019). Immunohistochemical expression of ABCB5 as a potential prognostic factor in uveal melanoma. Appl. Sci., 9.","DOI":"10.3390\/app9071316"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: Digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/1\/184\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:06:15Z","timestamp":1760159175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/1\/184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["molecules26010184"],"URL":"https:\/\/doi.org\/10.3390\/molecules26010184","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}